Helicobacter pylori Diagnostics Market Size, Share, Scope and Forecast Report 2023-2031

InsightAce Analytic Pvt. Ltd. Announces Market Assessment Report “Global Helicobacter pylori Diagnostics Market Size, Share and Trends Analysis Report by Technology (Immunoassays, POC, Molecular Diagnostics), End User (Hospitals, Diagnostic Laboratories, Clinics) – Market Outlook and Industry Analysis 2031”

this Global Helicobacter pylori Diagnostics Market It is expected to reach over US$994.69 million by 2031, with a CAGR of 6.20% during the forecast period.

Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1765

The Gram-negative aerobic bacterium Helicobacter pylori (H. pylori) is commonly found in the stomach and is essential for maintaining the gastric environment. Spiral-shaped bacteria can cause H. pylori infection to penetrate the esophagus, small intestine, and stomach walls, making it more likely to cause stomach cancer, peptic ulcers, and chronic gastritis.

The increasing number of gastric ulcer patients is one of the most important and critical reasons that is likely to boost the growth of the Helicobacter pylori diagnostics market. Geriatrics is becoming more common around the world, there is a growing need for point-of-care testing equipment, non-invasive testing is becoming more popular, and diagnostic testing is easily available.

List of prominent players in the Helicobacter pylori diagnostics market:

• Abbott
• Agilent Technologies
• alpha lab
• Avanos Medical Devices.
• Black & Decker
• Bio-Rad Laboratories
• Cardinal Health
• Certified Biotechnology Company
• CorisBioconcept SPRL
• EKF Diagnosis
• epitope diagnosis
• Exalenz Biosciences Ltd.
• F.Hofmann-LaRoche Ltd.
• Gulf Coast Sciences Corporation
• Harald Health
• Helena Laboratories Inc.
• HORIBA Europe GmbH
• industrial company of medellin
• Meridian Biosciences
• QJ
• Explore Diagnostics
• Quidel Corporation.
• Diagnosis of hydrops
• Takara Bio Co., Ltd.
• Thermo Fisher Scientific

Market dynamics:

driver-

The major market drivers are the demand for personalized antibiotic treatments and increasing cost-effectiveness of diagnostics. Pre- and post-surveillance testing will become more popular as the use of antibiotic regimens increases due to the availability of affordable antibiotics and shortening of treatment duration. Additionally, the rising prevalence of Helicobacter pylori infection, the requirement for early symptom recognition, and improvements in diagnostic technology are aiding the market growth.

challenge:

Over the forecast timeframe, market expansion for H. pylori testing is likely to be limited by factors such as a shortage of technical experts and a lack of understanding of the benefits of testing in emerging countries. The main obstacle to market expansion will be competitive pricing pressure.

Regional trends:

The demand for H. pylori diagnostics in Asia is driven by the high incidence of infectious diseases in the region. The popularity of these tests is expected to increase due to poor sanitation and medical infrastructure in countries like India. Furthermore, leading market players will significantly drive the regional market in the coming years by launching new products and building new manufacturing facilities.

Curious about the latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/1765

Recent developments:

• In October 2018, DiaSorin SpA and Meridian Bioscience, Inc. announced a strategic collaboration under which DiaSorin SpA subsidiaries DiaSorin Inc. and Meridian Bioscience, Inc. will market DiaSorin’s FDA-approved Helicobacter pylori stool antigen test for the detection of Helicobacter pylori bacteria for its global Meridian brand of automated LIAISON platforms. As part of this collaboration, Meridian and DiaSorin will begin collaborative sales and marketing efforts to hospitals and reference laboratories in the United States. In addition to royalties received under the previous agreement, Meridian will receive royalties on the sale of the LIAISON H. pylori stool antigen test in the United States and now the United Kingdom.

Helicobacter pylori Diagnostics Market Segmentation-

By technology-

• Immunoassay
• POC
• molecular diagnostics

By the end user-

• Hospital
• diagnostic laboratory
• Clinic

By Region-

North America-

Europe-

• Germany
• U.K.
• France
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific

Latin America-

• Brazil
• Argentina
• Rest of Latin America

Middle East and Africa –

• gulf cooperation council countries
• South Africa
• Middle East and Rest of Africa

For more customization@ https://www.insightaceanalytic.com/report/helicobacter-pylori-diagnostic-market/1765

about Us:

InsightAce Analytic is a market research and consulting firm that helps clients make strategic decisions. Our qualitative and quantitative market intelligence solutions address the market and competitive intelligence needs you need when scaling your business. We help clients gain competitive advantage by identifying untapped markets, exploring new and competitive technologies, segmenting potential markets, and repositioning products. Our expertise is the timely and cost-effective delivery of syndicated and customized market intelligence reports with in-depth analysis with key market insights.

contact us:

InsightAce Analytics Pte Ltd
Phone: +1 718 593 4405
e-mail: (email protected)

On-site visit: www.insightaceanalytic.com
Follow us on LinkedIn @bit.ly/2tBXsgS
Follow us on Facebook @bit.ly/2H9jnDZ